Transurethral Enucleation and Resection of Prostate in Patients With Benign Prostatic Hyperplasia by Plasma Kinetics

Liu, Chunxiao; Zheng, Shaojiang; Li, Hu‐Lin; Xu, Kai

doi:10.1016/j.juro.2010.08.037

Cited by 107 publications

(138 citation statements)

References 15 publications

Supporting

Mentioning

130

Contrasting

Unclassified

Order By: Relevance

“…The TUERP procedure was performed using the Gyrus Plasmakinetic SuperPulse System (Gyrus Medical, Cardiff, UK) with PlasmaSect electrodes, operated with a cutting power of 160 W and a coagulating power of 80 W [10]. The TUERP technique has been described in detail elsewhere [6]. Briefly, this technique involved retrograde enucleation of the prostatic adenoma lobes following triradiate bladder neck incisions.…”

Section: Surgical Proceduresmentioning

confidence: 99%

See 1 more Smart Citation

Long-term Follow-up of Transurethral Enucleation Resection of the Prostate for Symptomatic Benign Prostatic Hyperplasia

Peng¹,

Zhihai²,

Jiao³

et al. 2016

View full text Add to dashboard Cite

Abstract:Transurethral enucleation resection of the prostate is safe and feasible for the treatment of symptomatic benign prostatic hyperplasia (BPH). However, long-term results of this treatment in patients with BPH have not been reported. To assess the efficacy and safety of this procedure, this study retrospectively evaluated long-term outcomes in 1400 consecutive patients who underwent transurethral enucleation resection of the prostate for BPH between 2008 and 2014. Patients were followed up at 1, 3, 6, and 12 months, and every year thereafter. At a median follow-up of 70.1 months, mean Qmax increased from 6.43 to 22.1 ml/s and mean IPSS decreased from 22.3 to 2.9. PVR decreased from 123.0 to 12.0 cc, and mean TRUS volume decreased from 65.4 to 21.4 ml (P<0.0000). QOL score improved from 4.96 to 1.0, and PSA concentrations decreased from 6.87 to 0.75 ng/ml (P<0.0000). Complications included bladder neck contracture in 1.0% of patients and urethral stricture in 1.3%. These long-term results showed that transurethral enucleation resection of the prostate is durable, safe, and effective for patients with BPH, with patients not requiring reoperation.

show abstract

Section: Surgical Proceduresmentioning

confidence: 99%

“…A prospective randomized study comparing TUERP and TURP demonstrated the efficacy of TUERP, as shown by improvements in subjective and objective parameters [5][6][7][8][9]. Less is known, however, about the long-term (>5 years) efficacy, safety, and durability of TUERP.…”

Section: Introductionmentioning

confidence: 99%

Long-term Follow-up of Transurethral Enucleation Resection of the Prostate for Symptomatic Benign Prostatic Hyperplasia

Peng¹,

Zhihai²,

Jiao³

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Thus, several studies have been conducted to find a new, safe, and efficient technology that combines the advantages of open and minimally invasive surgery [2,8]. Laser prostatectomy is a promising surgical technique [9][10][11].…”

Section: Discussionmentioning

confidence: 99%

“…A variety of surgical methods are available, such as "orange peel" type [15], "fish scale" type [16], and transurethral dividing vaporesection [17]. Recently, more studies have verified the safety and efficiency of the enucleation technique to treat BPH since the report of Gilling et al [10,18].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Benign Prostatic Hyperplasia Treatment by Transurethral Enucleation of the Prostate Using a 2-μm Laser

Zhou

et al. 2015

Indian J Surg

View full text Add to dashboard Cite

This study investigates the efficacy of benign prostatic hyperplasia (BPH) treatment by prostate transurethral enucleation using a 2-μm laser. A total of 107 patients with BPH were treated by prostate transurethral enucleation using a RevoLix 2-μm laser surgery system. Bleeding volume, operation time, catheterization time, voiding situation, maximum urinary flow rate, and hospital stay were observed. The mean operation time was 74 min±12 min (range 45 to 150 min), the mean follow-up period was 2 to 6 months, the mean catheter time was 5 days, and the mean peak urinary flow rate increased from 6.3±0.6 to 17.5±1.5 mL/s. The International Prostate Symptom Score and quality of life significantly declined (p<0.01). No significant differences were observed in the hemoglobin and blood electrolytes before and after operation. Prostate transurethral enucleation using a 2-μm laser is safe and efficient for BPH treatment.

show abstract

Open Prostatectomy and Standard Endosurgery

Autorino

Nunzio²

2013

Male LUTS/BPH Made Easy

View full text Add to dashboard Cite

Transurethral Enucleation and Resection of Prostate in Patients With Benign Prostatic Hyperplasia by Plasma Kinetics

Abstract: Transurethral enucleation and resection of the prostate appears to be the modern alternative to transurethral resection of the prostate and open prostatectomy for bladder outlet obstruction due to benign prostatic hyperplasia. It may be done in glands up to 250 gm.

Cited by 107 publications

References 15 publications

Long-term Follow-up of Transurethral Enucleation Resection of the Prostate for Symptomatic Benign Prostatic Hyperplasia

Long-term Follow-up of Transurethral Enucleation Resection of the Prostate for Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia Treatment by Transurethral Enucleation of the Prostate Using a 2-μm Laser

Open Prostatectomy and Standard Endosurgery

Contact Info

Product

Resources

About